Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
F&FTSE:357A 20 EBITDA Margin % is 7.56% as of Mar. 2026, which is 9% above its 10-year median of 6.93. GuruFocus rates TSE:357A with a GF Score™ of 20/100.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. F&F's EBITDA for the
six
months ended in Mar. 2026 was 円246 Mil. F&F's Revenue for the
six
months ended in Mar. 2026 was 円3,259 Mil. Therefore, F&F's EBITDA margin for the quarter that ended in Mar. 2026 was 7.56%.
F&F (TSE:357A) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
F&F EBITDA Margin % Related Terms
F&F EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for F&F's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, F&F's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
F&F EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, F&F's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where F&F's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
F&F (TSE:357A) has a EBITDA Margin % of 7.56% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on F&F and its competitors. This is near median its historical median of 6.93. Over the past decade, F&F's EBITDA Margin % has ranged from 6.67 to 8.17.
Is F&F's EBITDA Margin % too high?
F&F's current EBITDA Margin % of 7.56% is near median its 10-year median of 6.93. Over the past 10 years, this metric has ranged from a low of 6.67 to a high of 8.17. The Healthcare Providers & Services industry median EBITDA Margin % is 10.25. F&F's value of 7.56% is 26.2% below this industry median. Overall, F&F has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does F&F's EBITDA Margin % compare to ?
F&F's EBITDA Margin % of 7.56% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.25. F&F's value of 7.56% is 26.2% below this benchmark. Historically, F&F's own EBITDA Margin % has ranged from 6.67 to 8.17 over the past decade. While the company's 10-year median is 6.93 vs. the industry median of 10.25, F&F has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.25, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. F&F's current EBITDA Margin % of 7.56% is 26.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on F&F and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. F&F's current EBITDA Margin % is 7.56%, which is near median its own 10-year median of 6.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is F&F stock overvalued right now?
F&F (TSE:357A) has a current EBITDA Margin % of 7.56%. The current EBITDA Margin % is 7.56%, which is near median its 10-year median of 6.93 and 26.2% below the Healthcare Providers & Services industry median of 10.25. F&F's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For F&F (TSE:357A), the current EBITDA Margin % is 7.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
F&F Inc is a company that creates pharmacies of the future through its insurance pharmacy business and healthcare system development. The services offered by the company are Health Check System, Insurance Pharmacy, Family pharmacist, Medical Mall, Home medical care, Business start-up support, and Nutritional and dietary advice.
20GF Score
Get the complete analysis for TSE:357A
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:357A has been successfully added to your 
